Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 22709388)

1.

The rise and fall of the lyme disease vaccines: a cautionary tale for risk interventions in American medicine and public health.

Aronowitz RA.

Milbank Q. 2012 Jun;90(2):250-77. doi: 10.1111/j.1468-0009.2012.00663.x. Review.

2.

Vaccines against Lyme disease: What happened and what lessons can we learn?

Poland GA.

Clin Infect Dis. 2011 Feb;52 Suppl 3:s253-8. doi: 10.1093/cid/ciq116. Review.

3.

Correcting a public health fiasco: The need for a new vaccine against Lyme disease.

Plotkin SA.

Clin Infect Dis. 2011 Feb;52 Suppl 3:s271-5. doi: 10.1093/cid/ciq119.

4.

Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial.

Sikand VK, Halsey N, Krause PJ, Sood SK, Geller R, Van Hoecke C, Buscarino C, Parenti D; Pediatric Lyme Vaccine Study Group.

Pediatrics. 2001 Jul;108(1):123-8.

PMID:
11433064
5.

Human Lyme disease vaccines: past and future concerns.

Nardelli DT, Munson EL, Callister SM, Schell RF.

Future Microbiol. 2009 May;4(4):457-69. doi: 10.2217/fmb.09.17. Review.

PMID:
19416014
6.

The Lyme vaccine: a cautionary tale.

McSweegan E.

Epidemiol Infect. 2007 Jan;135(1):9-10. Epub 2006 Oct 26. No abstract available.

7.

The Lyme disease vaccine--a public health perspective.

Shen AK, Mead PS, Beard CB.

Clin Infect Dis. 2011 Feb;52 Suppl 3:s247-52. doi: 10.1093/cid/ciq115. Review.

8.

The Lyme vaccine: a cautionary tale.

Nigrovic LE, Thompson KM.

Epidemiol Infect. 2007 Jan;135(1):1-8. Epub 2006 Aug 8. Review.

9.

[The origin of informed consent].

Mallardi V.

Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27. Italian.

PMID:
16602332
10.

Strengthening vaccination policies in Latin America: an evidence-based approach.

Tapia-Conyer R, Betancourt-Cravioto M, Saucedo-Martínez R, Motta-Murguía L, Gallardo-Rincón H.

Vaccine. 2013 Aug 20;31(37):3826-33. doi: 10.1016/j.vaccine.2012.12.062. Epub 2013 Jan 25. Review.

PMID:
23357196
11.

Preview: Lyme disease vaccines.

Donnelly EF.

Med Health R I. 1998 Nov;81(11):373-5.

PMID:
15580796
12.

The prevention of Lyme disease with vaccine.

Poland GA, Jacobson RM.

Vaccine. 2001 Mar 21;19(17-19):2303-8. Review.

PMID:
11257352
13.

[Death of a vaccine--the fall of LYMErix].

Zündorf I, Dingermann T.

Pharm Unserer Zeit. 2008;37(1):38-9. German. No abstract available.

PMID:
18081078
14.

Progress and controversy surrounding vaccines against Lyme disease.

Hanson MS, Edelman R.

Expert Rev Vaccines. 2003 Oct;2(5):683-703. Review.

PMID:
14711329
15.

Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT.

MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. Erratum in: MMWR Morb Mortal Wkly Rep. 2003 Feb 14;52(06):113.

16.

Guidelines, editors, pharma and the biological paradigm shift.

Singh AR, Singh SA.

Mens Sana Monogr. 2007 Jan;5(1):27-30. doi: 10.4103/0973-1229.32176.

17.

When a vaccine is safe.

[No authors listed]

Nature. 2006 Feb 2;439(7076):509. No abstract available.

PMID:
16452935
18.

The complicated task of monitoring vaccine safety.

Ellenberg SS, Chen RT.

Public Health Rep. 1997 Jan-Feb;112(1):10-20; discussion 21. Review.

19.

Development of orphan vaccines: an industry perspective.

Lang J, Wood SC.

Emerg Infect Dis. 1999 Nov-Dec;5(6):749-56. Review.

20.

Lyme vaccine demonized by advocacy groups.

McSweegan E.

Nature. 2006 Mar 16;440(7082):278. No abstract available.

PMID:
16541048
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk